Individualized Pharmacokinetic Monitoring Results in Less Aminoglycoside‐Associated Nephrotoxicity and Fewer Associated Costs
Authors:
- 1 April 2001
- journal article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 21 (4) , 443-451
Abstract
Study Objective. To examine the impact of individualized pharmacokinetic monitoring (IPM) on the development of aminoglycoside‐associated nephrotoxicity (AAN).Design. Retrospective case‐control study.Setting. Two teaching hospitals.Subjects. Two thousand four hundred five patients who received aminoglycosides.Intervention. Aminoglycoside therapy dosed by either IPM or physicians' directions.Measurements and Main Results. Patients receiving IPM were significantly less likely to develop AAN by both univariate (7.9% vs 13.2%, p=0.02) and multivariate methods (odds ratio 0.42, p=0.002). Female sex was protective against AAN. Age 50 years and above, high initial aminoglycoside trough, long duration of therapy, and concurrent piperacillin, clindamycin, or vancomycin increased risk of AAN. We estimated that IPM decreased AAN costs by $90,995/100 patients.Conclusion. Individualized pharmacokinetic monitoring significantly decreased the frequency of AAN and its associated economic costs.Keywords
This publication has 29 references indexed in Scilit:
- Cost Considerations in Therapeutic Drug Monitoring of AminoglycosidesClinical Pharmacokinetics, 1994
- Incidence of and Significant Risk Factors for Aminoglycoside-Associated Nephrotoxicity in Patients Dosed by Using Individualized Pharmacokinetic MonitoringThe Journal of Infectious Diseases, 1993
- Does Accepting Pharmacokinetic Recommendations Impact Hospitalization? A Cost-Benefit AnalysisTherapeutic Drug Monitoring, 1990
- Impact of a Clinical Pharmacokinetic Service on Patients Treated with AminoglycosidesTherapeutic Drug Monitoring, 1990
- EDITORIAL REVIEW: MECHANISMS OF AMINOGLYCOSIDE NEPHROTOXICITYClinical and Experimental Pharmacology and Physiology, 1989
- Comparison of gentamicin and tobramycin nephrotoxicity in patients receiving individualized-pharmacokinetic dosing regimensBiopharmaceutics & Drug Disposition, 1982
- Double-Blind Comparison of the Nephrotoxicity and Auditory Toxicity of Gentamicin and TobramycinNew England Journal of Medicine, 1980
- Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: Gentamicin in burn patientsJournal of Pharmacokinetics and Biopharmaceutics, 1976
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976
- Modelling of individual pharmacokinetics for computer-aided drug dosageComputers and Biomedical Research, 1972